Navigation Links
TPI to Develop New Formulation for Flagship Product Gingko Mihuan
Date:11/3/2011

iod to 3 years from the current 2 years for oral liquid form. The new capsule formulation is expected to support the revenue growth of GMOL at approximately 30% year over year and improving the gross margin of GMOL products to 75% or higher. TPI will also apply for patent protection for the new capsule formulation. The research and development cost is estimated at $1-2 million. TPI expects to begin production of the new capsule formulation in approximately 12-15 months.

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and active pharmaceutical ingredients (API). TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI and GMOL, please visit:  http://www.tianyinpharma.com and www.sfda.gov.cn (Chinese version).

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Newly Launched US BioDesign to Provide OEM Development/Manufacturing Services to Medical Device Customers
2. JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development
3. AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy
4. ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts
5. CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies
6. Laparoscopic Surgeons Develop Fluorescent Light Technique to Improve Pancreatic Cancer Detection
7. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
8. 50 Pharma Companies Worldwide Now Use Codexis In Process Development
9. Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D
10. FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays
11. VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... China , announced that Sinovac Beijing, ... the Certificate of Good Manufacturing Practices for Pharmaceutical ... Food Administration (CFDA) for its proprietary vaccines, its ... filing and packaging facility. The GMP certificate covers ...
(Date:5/24/2013)... England and BOSTON , May ... drug discovery and development company, is pleased to announce that it ... Consultant to augment the Company,s business development capabilities in ... has more than 15 years of experience in business development, licensing ... Perlegen Sciences, Inc., Roche Pharma ( Japan ), Nippon ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Bleeding in Patients Treated for Acute Coronary Syndromes,(ACS) ... Year, NEW ORLEANS, March 26, 2007 /PRNewswire/ -- ... acute coronary syndrome,(ACS) patients in the "Angiomax(R) (bivalirudin) ... outcomes compared with,more complicated standard therapy, confirming previous ...
... 2 Findings Suggest Improved Outcomes in Carotid,Artery ... /PRNewswire-FirstCall/ --,Positive 30-day results from two Abbott ... with positive results by,physicians with a variety ... in patients who are not favorable,candidates for ...
Cached Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4
(Date:5/25/2013)... Plains, NJ (PRWEB) May 25, 2013 ... iPhone. The universal app version of Word Hunt ... app versions of Concentration, Edge Match, Flash 2, Sudoku and ... , The brain games’ gameplay and revolutionary lifetime brain fitness ... 4 inch displays. , “100 years of brain fitness measurement ...
(Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...
(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...
(Date:5/25/2013)... 2013 Ayurveda is the traditional ... or wisdom of life". While a medical science, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... It believes that in order to re-establish optimal health, we ... then adopt a life style which brings us back into ...
(Date:5/25/2013)... May 25, 2013 The current residents of ... parents, and the B2B staff all came together Saturday, May ... an array of Indian Cuisine, the residents got up to ... helping them on their road to recovery, and giving them ... and Alcohol center in 2010 after realizing the need for ...
Breaking Medicine News(10 mins):Health News:Acuity Games Apps Come to the iPhone 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... more sensitive to early signs of Alzheimer,s dementia than ... School of Medicine in St. Louis. Doctors often ... testing them with a variety of cognitive tasks, such ... of objects. Washington University researchers developed a different approach. ...
... By Randy Dotinga HealthDay Reporter , MONDAY, Sept. ... the devastation suffered by men when their wives or girlfriends ... were almost 40 percent more likely than other men to ... risk of hospitalization among the men was very small, and ...
... Inc. is presenting new data in five posters and ... the company,s radioprotectant Ex-RAD at the 56th Annual Meeting ... Maui, Hawaii. In vivo studies show that Ex-RAD, ... versus placebo-treated groups in mice exposed to lethal whole ...
... best practice and endorsement of evidence-based medicine, the American ... and released a clinical practice guideline, which found a ... a way to treat fractures in the spine. ... to ensure that patients receive high quality care. ...
... and military efforts continuing in Afghanistan, UCLA has helped ... forces medical personnel in critical combat casualty care. The ... program,s developers say, but civilian care as well. ... the field during Operation Iraqi Freedom and Operation Enduring ...
... first studies to focus exclusively on the outcomes ... http://www.mayoclinic.org/prostate-cancer/ ) researchers have found that surgery provides ... and Fox Chase Cancer Center ( http://www.fccc.edu/ ) ... aggressive forms of prostate cancer who had radical ...
Cached Medicine News:Health News:Friends, family detect early Alzheimer's signs better than traditional tests 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 3Health News:Male Partners of Breast Cancer Patients May Suffer Depression 2Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 2Health News:Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting 3Health News:New guideline finds no evidence for a popular back procedure 2Health News:New guideline finds no evidence for a popular back procedure 3Health News:UCLA develops combat casualty care educational program for US armed forces 2Health News:UCLA develops combat casualty care educational program for US armed forces 3Health News:Surgery found effective for patients with aggressive prostate cancer 2
... for a complete line of diagnostic coronary ... with the quality, reliability and precise performance ... in catheter technology. All of our coronary ... to help minimize the frustration and excess ...
The Polaris-DX steerable diagnostic catheter is designed for comfort and ergonomic handling during mapping procedures....
... of the PARAHISIAN catheter, combines an octapolar ... permits the use of only one catheter ... His bundle electrograms. The "two catheters in ... a single venipuncture. The disadvantages of using ...
... HIS diagnostic catheters provide the ... curve that allows for placement ... bundle. In addition, the soft ... the risk of perforation while ...
Medicine Products: